We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Childhood Origins of Asthma (COAST) (COAST)

This study is ongoing, but not recruiting participants.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00204841
First Posted: September 20, 2005
Last Update Posted: March 31, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Wisconsin, Madison
September 12, 2005
September 20, 2005
March 31, 2017
October 1998
May 2018   (Final data collection date for primary outcome measure)
Evaluate the children longitudinally for the inception and progression of asthma. [ Time Frame: Birth through puberty. ]
Not Provided
Complete list of historical versions of study NCT00204841 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Childhood Origins of Asthma (COAST)
Rhinovirus Infection and Asthma in Childhood and Adolescents
Although asthma is likely to be a heterogeneous disease or syndrome, three factors and/or events repetitively emerge for their ability to significantly influence asthma inception in the first decade of life: immune response aberrations, which appear to be defined best by the concept of cytokine dysregulation; lower respiratory tract infections (in particular RSV); and some form of gene by environment interaction that needs to occur at a critical time period in the development of the immune system or the lung. It remains to be firmly established, however, how any one or all of these factors, either independently or interactively, influence the development of childhood asthma. Thus, our efforts to determine and define the importance of these three factors to asthma pathogenesis are the focus and goal of this current grant application.
No more description necessary.
Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:
nasal mucus samples, cord blood, peripheral blood samples, nasal cell brushing samples, cell lines
Non-Probability Sample
High risk birth cohort of children (one or both parents have allergies and/or asthma).
  • Asthma
  • Allergy
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
300
May 2018
May 2018   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • children who had one or more parent with a history of allergy or asthma

Exclusion Criteria:

  • pre term infants
  • low birth weight infants
  • respiratory distress at birth
Sexes Eligible for Study: All
up to 2 Minutes   (Child)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00204841
1998-129
P01HL070831 ( U.S. NIH Grant/Contract )
No
Not Provided
Not Provided
University of Wisconsin, Madison
University of Wisconsin, Madison
  • National Institutes of Health (NIH)
  • National Heart, Lung, and Blood Institute (NHLBI)
Principal Investigator: Robert F Lemanske, Jr., MD University of Wisconsin, Madison
University of Wisconsin, Madison
March 2017